Delisting riskEarnings in 2d
Celularity
Develops placenta-derived cell therapies for longevity and age-related disease.
$1.48
After-hours close−0.09 (−5.63%)
At close$1.57(−25.24%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | — | — | — |
| Aug 2026 | — | — | — |
| May 2026 | — | −$0.59 | — |
| Apr 2026 | −$1.50 | −$0.95 | +36.7% |
| Nov 2025 | −$1.50 | −$0.88 | +41.3% |
| Aug 2025 | — | −$0.84 | — |
The latest year is open to everyone — the 24 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Dec 2024 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| Jul 2024 | |||
| Jan 2024 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | — | — | — | — | — | — |
| Aug 31, 2026 | — | — | — | — | — | — |
| May 8, 2026 | — | −$0.59 | — | — | — | — |
| Apr 30, 2026 | −$1.50 | −$0.95 | +36.7% | $4.1M | $4.1M | 0.0% |
| Nov 14, 2025 | −$1.50 | −$0.88 | +41.3% | — | $5.3M | — |
| Aug 29, 2025 | — | −$0.84 | — | — | $11.4M | — |
The latest year is open to everyone — the 24 quarters behind it read with an account. Sign in | ||||||
| May 8, 2025 | ||||||
| Dec 6, 2024 | ||||||
| Nov 7, 2024 | ||||||
| Sep 27, 2024 | ||||||
| Jul 31, 2024 | ||||||
| Jan 2, 2024 | ||||||
| Aug 14, 2023 | ||||||
| May 22, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 16, 2021 | ||||||
| May 24, 2021 | ||||||
| Mar 4, 2021 | ||||||
| Nov 16, 2020 | ||||||
| Aug 13, 2020 | ||||||
| May 14, 2020 | ||||||
| Mar 23, 2020 | ||||||
| Nov 13, 2019 | ||||||
| Aug 7, 2019 | ||||||
| Mar 31, 2019 | ||||||